AI aims to revolutionize cancer trial enrollment for 50,000 patients
Knowledge-focused
Recruiting now
This study is testing whether an artificial intelligence (AI) tool can help match cancer patients with the right clinical trials. Researchers will enroll up to 50,000 people with various cancers to see if the AI improves trial enrollment rates and patient outcomes. The goal is to…
Sponsor: Massive Bio, Inc. • Aim: Knowledge-focused
Last updated Jun 11, 2026 12:12 UTC